Table 2.
Controls (N = 32) | HNPCC (N = 16) | |
---|---|---|
|
||
Grade of dysplasia | ||
Low | 22 (69%) | 13 (81%) |
High | 10 (31%) | 3 (19%) |
Presence of necrosis | 6 (19%) | 1 (6%) |
Presence of serrated architecture | 4 (13%) | 4 (25%) |
Percent of villous component | ||
Low (<25%) | 28 (88%) | 16 (100%) |
Intermediate (25-50%) | 3 (9%) | 0 (0%) |
High (>50%) | 1 (3%) | 0 (0%) |
Intra-adenomatous mitotic figures | ||
Low (<5/HPF) | 24 (75%) | 14 (87%) |
Intermediate (5-10/HPF) | 8 (25%) | 2 (13%) |
High (>10/HPF) | 0 (0%) | 0 (0%) |
Adenoma-infiltrating lymphocytes | ||
Low (<5/HPF) | 28 (88%) | 4 (25%) |
Intermediate (5-10/HPF) | 2 (6%) | 5 (31%) |
High (>10/HPF) | 2 (6%) | 7 (44%) |
Intra-adenomatous apoptotic bodies | ||
Low (<5/HPF) | 5 (16%) | 9 (56%) |
Intermediate (5-10/HPF) | 13 (41%) | 5 (31%) |
High (>10/HPF) | 14 (43%) | 2 (13%) |
Values are given as number (percentage).
HPF: high power field (400x)